Pharmacokinetics and drug therapy in neonates
Neonates include both full term and preterm infants up to 28 days of age. The heterogeneity and rapid physiologic change of neonates affect all aspects of pharmacokinetics such as absorption, distribution, metabolism, and elimination. This feature should be considered in determining the dose and reg...
Main Author: | Hye Jung Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pediatric Emergency Medicine
2017-06-01
|
Series: | Pediatric Emergency Medicine Journal |
Subjects: | |
Online Access: | http://pemj.org/upload/pdf/pemj-2017-00059.pdf |
Similar Items
-
Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age
by: Domenico Umberto De Rose, et al.
Published: (2020-08-01) -
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
by: Rubén Varela-Fernández, et al.
Published: (2020-03-01) -
Pharmacokinetics and metabolism in drug design /
by: 464017 Smith, Dennis A., et al.
Published: (2006) -
Optimal control in pharmacokinetic drug administration
by: Norbert Hungerbühler
Published: (2022-03-01) -
Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates
by: Mario Regazzi, et al.
Published: (2023-12-01)